| Family: | Direxion Shares |
| Name: | Direxion Daily Pharmaceutical & Medical Bull 3X ETF |
| Inception Date: | 15-Nov-2017 |
| Termination Date: | |
| Investment Objective: | The Direxion Daily Pharmaceutical & Medical Bull 3X ETF seek daily investment results, before fees and expenses of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. To be eligible for inclusion in the Index, stocks must satisfy one of the following combined size and liquidity criteria: (1) have a float-adjusted market capitalization above $300 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the Index rebalancing reference date) above 50%; (2) have a float-adjusted market capitalization above $500 million with a float-adjusted liquidity ratio above 90%; or (3) have a float-adjusted market capitalization above $400 million with a float-adjusted liquidity ratio above 150%. The Index is rebalanced quarterly. |
| Prospectus | |
| Top 10 Holdings | ||
| Derivatives offset | -218.6085% | |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | 75.8668% | |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | 64.4578% | |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | 40.3506% | |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | 37.9334% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 19.3227% | |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | X9USDGLDS | 8.0278% |
| DREYFUS GOVT CASH MAN INS | 3.5197% | |
| CRINETICS PHARMACEUTICALS IN | CRNX | 2.4979% |
| Definium Therapeutics, Inc | DFTX | 2.0778% |
| Top 10 Holdings Weight: | 35.4% |
| Number of Holdings: | 73 |
| Shares Outstanding: | 1,200,001 |
| Total Net Assets: | 21,912,020 |
| NAV: | 18.20 |
| Net Expense Ratio: | 0.98% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | NYSE Intellidex proprietary model |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Pharmaceuticals |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | Leveraged (3x) |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
